Preview

Современная ревматология

Расширенный поиск

Особенности клинических и лабораторных проявлений системной красной волчанки

https://doi.org/10.14412/1996-7012-2012-761

Полный текст:

Аннотация

Обзор литературы посвящен особенностям клинических и лабораторных проявлений системной красной волчанки (СКВ). Данные литературы и собственный опыт авторов свидетельствуют о сложности верификации достоверного диагноза, особенно при атипичных вариантах болезни. Огромное значение имеют правильная оценка клинических и лабораторных проявлений СКВ у каждого больного, выявление обострения основного заболевания и сопутствующей патологии, оценка влияния проводимой терапии, поиск прогностических маркеров исхода.

Литература

1. <div><p>Клинические рекомендации по ревматологии. Под ред. акад. Е.Л. Насонова. 2-е изд. М.: ГЭОТАР-Медиа, 2010; 429—81.</p><p>Иванова М.М. Системная красная волчанка. В кн.: Диффузные болезни соединительной ткани. М.: Медицина, 2004; 253—41.</p><p>Tan E.M., Cohen A.S., Fries J.F. et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthr Rheum 1982; 25: 1271—7.</p><p>Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthr Rheum 1997; 40: 1725.</p><p>Calvo-Alen J., Bastian H., Straaton K. et al. Identification of patient subsets among those presumptively diagnosed with, referred, and/or followed up for systemic lupus erythematosus at the large tertiary care center. Arthr Rheum 1995; 38: 1475—84.</p><p>Bertsias G., Salmon J., Boumpas D. Therapeutic opportunites in systemic lupus erythematosus: state of the art and prospects for the new decade. Ann Rheum Dis 2010; 69: 1603—11.</p><p>Petri M., Orbai A.-M., Alarcon G. et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics Classification Criteria for systemic lupus erythematosus. Arthr Rheum 2012; 64(8): 2677—86.</p><p>Rovin B.H., Tang Y., Sun J. et al. Clinical significance of fever in the systemic lupus erythematosus patient receiving steroid therapy. Kidney Int 2005; 68(2): 747—59.</p><p>Petri M. Musculoskeletal complications of SLE in the Hopkins Lupus Cohort: An update. Arthr Rheum 1995; 8(3): 137—45.</p><p>Fernandez A., Quintana G., Matteson E.L. et al. Lupus arthropathy: Historical evolution from deforming arthritis to rhupus. Clin Rheumatol 2004; 23: 523—6.</p><p>Garton M.J., Isenberg D.A. Clinical features of lupus myositis versus idiopathic myositis: A review of 30 cases. Br J Rheum 1997; 36: 1067—74.</p><p>Horowitz D., Marder G., Furie R. Musculoskeletal system: articular disease, bone metabolism. In: R. Lahita Systemic lupus erythematosus. 5th ed. Elsevier, 2011; 921 —44.</p><p>Crowson A.N., Magro C. The cutaneous pathology of lupus erythematosus: a review. J Cutaneous Pathol 2001; 28: 1—23.</p><p>Werth V., Keller C., Dutz J. Skin. In: R. Lahita. Systemic lupus erythematosus. 5th ed. Elsevier, 2011; 747—68.</p><p>Werth V.P. Clinical manifestations of cutaneous lupus erythematosus. Autoimmunity Rev 2005; 4: 296—302.</p><p>Giunta A., Picillo U., Maione S. et al. Spectrum of cardiac involvement in systemic lupus erythematosus: Echocardiographic, echo-Doppler observations and immunologic investigations. Acta Cardiol 1993; 48: 183—97.</p><p>Wang D.Y., Yan P.C., Yu W.L. et al. Comparison of different diagnostic methods for lupus pleuritis and pericarditis: A prospective 3 year study. J Formos Med Assoc 2000; 99: 375—80.</p><p>Jain D., Halushka M.K. Cardiac pathology of systemic lupus erythematosus. J Clin Pathol 2009; 62: 584—92.</p><p>Swigris J.J., Fischer A., Gillis J. et al. Pulmonary and thrombotic manifestations of systemic lupus erythematosus. Chest 2008; 133: 271 —80.</p><p>Quadrelli S., Alvarez C., Arce S. Pulmonary involvement of systemic lupus erythematosus: Analysis of 90 necropsies. Lupus 2009; 18: 1053—60.</p><p>Pasoto S.G., Borba E.F., Bonfa E. et al. Lupus pleuritis: a relevant factor for pulmonary tuberculosis. Lupus 2010; 19: 1585—90.</p><p>Carette S., Macher A.M., Nussbaum A. et al. Severe, acute pulmonary disease in patients with systemic lupus erythematosus: Ten years of experience at the National Institutes of Health. Sem Arthr Rheum 1984; 14: 52—9.</p><p>Sultan S.M., Ioannou Y., Isenberg D.A. A review of gastrointestinal manifestations of systemic lupus erythematosus. Rheumatology 1999; 38: 917—32.</p><p>Abraham S., Begum S., Isenberg D. Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis 2004; 63: 123—9.</p><p>Runyon B.A., LaBreque D.R., Anuras S. The spectrum of liver disease in systemic lupus erythematosus. Am J Med 1980; 69: 187—94.</p><p>Makary R., Davis C., Shuja S. Medium-and small-vessel vasculitis with large bowel infarction in systemic lupus erythematosus: A case report. Am J Gastroenterol 2009; 9: 1859—60.</p><p>Nguyen H., Niharika K. Intestinal pseudo-obstruction as a presenting manifestation of systemic lupus erythematosus. South Med J 2004; 97: 186—9.</p><p>Orellana C., Collado A., Hernandez M.V. et al. When does amyloidosis complicate systemic lupus erythematosus? Lupus 1995; 4: 415—7.</p><p>Dvorkina O., Ginzler E.M. Corticosteroid and nonsteroid anti-inflammatory drug use in systemic lupus erythematosus. In: Lahita R. Systemic lupus erythematosus. 5th ed. Elsevier, 2011; 1045—60.</p><p>Weening J.J., D'Agati V.D., Schwartz M.M. et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004; 5: 241—50.</p><p>Hiramatsu N., Kuroiwa T., Ikeuchi H. et al. Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions. Rheumatology (Oxford) 2008; 47: 702—7.</p><p>Bastian H.M., Roseman J.M., McGwin Jr. G. et al. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus 2002; 1: 152—60.</p><p>Levey A.S., Bosch J., Lewis J.B. et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Int Med 1999; 130: 461—70.</p><p>Siedner M.J., Gelber A.C., Rovin B.H. et al. Diagnostic accuracy study of urine dipstick in relation to 24-hour measurement as a screening tool for proteinuria in lupus nephritis. J Rheumatol 2008; 35: 84—90.</p><p>Tektonidou M.G. Renal involvement in the antiphospholipid syndrome (APS)-APS nephropathy. Clin Rev Allergy Immunol 2009; 36: 131—40.</p><p>Hanly J.G., Su L., Farewell V. et al. Prospective study of neuropsychiatric events in systemic lupus erythematosus. J Rheum 2009; 36: 1449—59.</p><p>Hanly J.G. The nervous system and lupus. In: Lahita R. Systemic lupus erythematosus. 5th ed. Elsevier, 2011; 727—46.</p><p>Campbell Jr. R., Cooper G.S., Gilkeson G.S. Two aspects of the clinical and humanistic burden of systemic lupus erythematosus: Mortality risk and quality of life early in the course of disease. Arthr Rheum 2008; 59: 458—64.</p><p>Bertsias G., Ioannidis J., Aringer M. et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 2010; 69: 2074—82.</p><p>Soo M.P.K., Chow S.K., Tan C.T. et al. The spectrum of ocular involvement in patients with systemic lupus erythematosus without ocular symptoms. Lupus 2000; 9: 511—4.</p><p>Peponis V., Kyttaris V.C., Tyradellis C. et al. Ocular manifestations of systemic lupus erythematosus: a clinical review. Lupus 2006; 15: 3—12.</p><p>Hepbum A.L., Narat S., Mason J.C. The management of peripheral blood cytopenias in systemic lupus erythematosus. Rheumatology 2010; 49: 2243—54.</p><p>Giannouli S., Voulgarelis M., Ziakas P.D. et al. Anaemia in systemic lupus erythematosus: From pathophysiology to clinical assessment. Ann Rheum Dis 2006; 65: 144—8.</p><p>Kuwana M., Kaburaki J., Okazaki Y. et al. Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2006; 45: 851—4.</p><p>Vila L.M., Alarcon G.S., McGwin Jr. et al. Reveille, Systemic lupus erythematosus in a multiethnic U.S. cohort, XXXVII: Association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual. Arthr Rheum 2006; 55: 799—806.</p><p>Schur P.H. Laboratory evaluation of patients with systemic lupus erythematosus. In: R. Lahita Systemic lupus erythematosus. 5th ed. Elsevier, 2011; 629—54.</p><p>Kasitanon N., Magder L.S., Petri M. Predictors of survival in systemic lupus erythematosus. Medicine (Baltimore) 2006; 85: 147—56.</p><p>Murakami M., Tsubata T., Shinkura R. et al. Acute lupus hemophagocytic syndrome: report of a case. Nefrologia 2010; 30(2): 247—51.</p><p>Насонов Е.Л., Баранов А.А. Иммунодиагностика ревматических заболеваний (методическое пособие). Ярославль, 2001; 56 с.</p><p>Александрова Е.Н., Новиков А.А., Насонов Е.Л. Современные стандарты лабораторной диагностики ревматических заболеваний. 2-е изд. М., 2012; 61 с.</p><p>Batnes E.V., Narain S., Naranjo A. et al. High sensitivity C-reactive protein on systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk. Lupus. 2005; 14: 576—82.</p><p>Weber M., Hayem G., Meyer O. et al. The Sapporo criteria for antiphospholipid syndrome. Arthr Rheum 2001; 44: 1965—6.</p><p>Piette J.-C., Wechsker B., Frances C. et al. Systemic lupus erythematosus and the antiphospholipid syndrome: reflection about the relevance of ARA criteria. J Rheum 1992; 20: 1835—7.</p><p>Насонов Е.Л. Антифосфолипидный синдром. М.: Литтерра, 2004; 440 с.</p><p>Laskin C.A., Spitzer K.A., Clark C.A. Pregnancy and reproductive concerns in systemic lupus erythematosus. In: R. Lahita Systemic lupus erythematosus. 5th ed. Elsevier, 2011; 655—72.</p><p>Barber C., Gold W.L., Fortin P.R. Infections in the lupus patient: perspectives on prevention. Curr Opin Rheum 2011; 23(4): 358—65.</p><p>Petri M. Infection in systemic lupus erythematosus. Rheum Dis Clin North America 1998; 24(2): 424—56.</p><p>Bernatsky S.R., Cooper G.S., Mill C. et al. Cancer screening in patients with systemic lupus erythematosus. J Rheum 2006; 33(1): 45—9.</p><p>Попкова Т.В., Лисицына Т.А. Рекомендации по ведению больных системной красной волчанкой в клинической практике (по материалам рекомендаций Европейской антиревматической лиги — EULAR). Совр. ревматол. 2011; 1: 4—12.</p><p>Bertsias G., Ioannidis J., Boletis J. et al. EULAR recommendations for the management of systemic lupus erythematosus. Report of a task force of the EULAR Standing Committee for International Clinical Studies including Therapeutics. Ann Rheum Dis 2008; 67: 195—205.</p><p>Mosca M., Tani C., Aringer M. et al. European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis 2010; 69: 1269—74.</p></div><br />


Для цитирования:


Клюквина Н.Г., Насонов Е.Л. Особенности клинических и лабораторных проявлений системной красной волчанки. Современная ревматология. 2012;6(4):40-48. https://doi.org/10.14412/1996-7012-2012-761

For citation:


Klyukvina N.G., Nasonov E.L. The clinical and laboratory manifestations of systemic lupus erythematosus. Modern Rheumatology Journal. 2012;6(4):40-48. (In Russ.) https://doi.org/10.14412/1996-7012-2012-761

Просмотров: 1014


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)